Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AFLIBERCEPT vs AGALSIDASE BETA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AFLIBERCEPT vs AGALSIDASE BETA: Safety Overview

Metric AFLIBERCEPT AGALSIDASE BETA
Total FAERS Reports 26,891 6,372
Deaths Reported 8,527 334
Death Rate 31.7% 5.2%
Hospitalizations 3,193 1,346
Average Patient Age 70.5 yrs 42.5 yrs
% Female Patients 50.9% 45.0%
Manufacturer Regeneron Pharmaceuticals, Inc. Genzyme Corporation
Route INTRAVITREAL INTRAVENOUS
Marketing Status Prescription Prescription